Axogen, Inc.'s next confirmed earnings release is scheduled for October 28, 2026.
| Earnings Date | 10/28/2026 |
As of June 30, 2026, Axogen, Inc. has 53.18M shares outstanding.
| Shares Outstanding | 53.18M |
As of June 30, 2026, Axogen, Inc. maintains a current ratio of 6.60, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.83, indicating elevated leverage, while an interest coverage ratio of -0.90 demonstrates limited ability to service its debt obligations.
| Current Ratio | 6.60 |
| Quick Ratio | 4.79 |
| Debt / Equity | 7.83 |
| Debt / EBITDA | -5.33 |
| Interest Coverage | -0.90 |
Over the twelve months ended June 30, 2026, Axogen, Inc. posted a negative return on equity (ROE) of -18.21, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.15, reflecting losses generated across the asset base. The company generates approximately 7.57M in revenue per employee across its workforce of 579.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.52 indicates how many times Axogen, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -18.21 |
| Return on Assets (ROA) | -13.15 |
| Revenue Per Employee | 7.57M |
| Employee Count | 579.50 |
| Inventory Turnover | 1.52 |
Over the twelve months ended June 30, 2026, Axogen, Inc. generated 4.39B in revenue and converted that into -586.14M in net income, yielding earnings per share of -11.67. EBITDA reached -65.78M, while operating income came in at -224.48M.
| Revenue | 4.39B |
| Gross Profit | 3.27B |
| Operating Income | -224.48M |
| Pretax Income | -586.14M |
| Net Income | -586.14M |
| EBITDA | -65.78M |
| EBIT | -224.48M |
| Earnings Per Share (EPS) | -11.67 |
As of June 30, 2026, Axogen, Inc. holds 1.95B in cash and equivalents against 350.59M in total debt, resulting in a net debt position of -1.65B. Total book value stands at 4.48B, with working capital of 2.97B providing operational flexibility.
| Cash & Cash Equivalents | 1.95B |
| Total Debt | 350.59M |
| Net Debt | -1.65B |
| Equity (Book Value) | 4.48B |
| Book Value Per Share | 84.19 |
| Working Capital | 2.97B |
Axogen, Inc. produced 262.90M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -149.16M in capital expenditures, free cash flow totaled 113.74M - equivalent to 2.29 per share.
| Operating Cash Flow | 262.90M |
| Capital Expenditures | -149.16M |
| Free Cash Flow | 113.74M |
| FCF Per Share | 2.29 |
Over the twelve months ended June 30, 2026, Axogen, Inc. posted a gross margin of 74.56, reflecting its pricing power and cost economics. The operating margin of -5.12 and net profit margin of -13.36 provide insight into operational efficiency.
| Gross Margin | 74.56 |
| Operating Margin | -5.12 |
| Pretax Margin | -13.36 |
| Profit Margin | -13.36 |
| EBITDA Margin | -1.50 |
Axogen, Inc.'s most recent stock split took place on July 11, 1994 with a 20:21 split ratio.
| Last Split Date | 7/11/1994 |
| Split Ratio | 20:21 |